Kventiax (Quetiapine)

Quetiapine works by blocking dopamine D2 receptors and serotonin 5‑HT2A receptors while also influencing 5‑HT1A, histamine H1 and adrenergic α1 receptors. This mixed antagonism balances neurotransmitter activity, reducing psychosis, moderating mood swings, and enhancing the effect of antidepressants in certain patients.

The appropriate dose of Kventiax is individualized by the prescribing clinician based on the specific diagnosis, severity of symptoms, patient age, metabolic status, and response to therapy. No fixed dosing regimen is provided here; the prescriber will set the dose and titration schedule.

The pregnancy category for quetiapine is listed as unknown, and safety data are limited. Use during pregnancy or lactation should only occur when the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made in consultation with a healthcare professional.

To order Kventiax, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kventiax (quetiapine) shares the broad receptor profile typical of atypical antipsychotics but is distinguished by relatively strong antihistamine and α1‑adrenergic blockade, which can cause sedation and orthostatic effects. Compared with agents such as risperidone or olanzapine, quetiapine may have a lower risk of prolactin elevation but a higher propensity for weight gain and drowsiness.

Store Kventiax at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat. Do not store in a refrigerator or freezer, and ensure the container is tightly closed when not in use.

Kventiax is taken orally as a tablet. It should be swallowed whole with water, with or without food, as directed by the prescriber. The tablet should not be chewed, crushed, or split unless specifically advised by a healthcare professional.

Serious adverse events include agranulocytosis, neuroleptic malignant syndrome, tardive dyskinesia, severe hypotension, and emergence of suicidal thoughts or behaviors. Patients should be monitored closely for signs of infection, unexplained fever, muscle rigidity, sudden changes in mood, or cardiovascular instability, and seek immediate medical attention if these occur.

Kventiax is contraindicated in individuals with known hypersensitivity to quetiapine or any of its excipients. Caution is advised for patients with uncontrolled cardiovascular disease, severe hepatic impairment, or a history of neuroleptic malignant syndrome. It should also be avoided in patients taking medications that strongly induce or inhibit CYP3A4 without appropriate dose adjustments.